- Experience with TPO agonist treatment in children in view of new guidelines2021 | Publication without faculty affiliation
- Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide2015 | First Faculty of Medicine
- Dopamine agonists treatment in Parkinson's disease: experience with Pergolide2000 | First Faculty of Medicine
- Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal2019 | First Faculty of Medicine
- Long-Term Opioid Agonist Treatment Participation after First Treatment Entry is Similar across 4 European Regions but Lower in Non-Nationals2018 | First Faculty of Medicine
- Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway2023 | First Faculty of Medicine
- Effect of PPAR-gamma agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitusPublication without faculty affiliation
- Effect of PPAR-gama agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitus2007 | First Faculty of Medicine
- The influence of PPAR-alfa agonist treatment on insulin sensitivity in patients with type 2 diabetes: the role of resistin and adiponectin (2)Publication without faculty affiliation
- The influence of PPAR-alfa agonist treatment on insulin sensitivity in patients with type 2 diabetes: the role of resistin and adiponectin (1)Publication without faculty affiliation
- Protein alterations induced by long-term agonist treatment of HEK293 cells expressing thyrotropin-releasing hormone receptor and G11alpha protein2010 | Faculty of Science
- Improvement of Insulin Sensitivity after Peroxisome Proliferator-Activated Receptor-α Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin Levels2006 | First Faculty of Medicine, Third Faculty of Medicine
- Perixome proliferator - activated receptor-alfa agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and imporves glucose homeostatis2003 | First Faculty of Medicine
- Perixome proliferator - activated receptor-alfa agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and imporves glucose homeostatis2003 | Faculty of Physical Education and Sport
- Serum concentrations of novel metabolic regulator FGF-21 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet and PPAR-alpha agonist treatmentPublication without faculty affiliation
- Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-alpha agonist treatment2011 | First Faculty of Medicine
- Large variations in all-cause and overdose mortality among >13,000 patients in and out of opioid maintenance treatment in different settings: a comparative registry linkage study2023 | First Faculty of Medicine
- Determination of mu-, delta- and kappa-opioid receptors in forebrain cortex of rats exposed to morphine for 10 days: Comparison with animals after 20 days of morphine withdrawal2017 | Faculty of Science, Central Library of Charles University
- Dopamine agonist-induced generalized edema in Parkinson's disease2009 | First Faculty of Medicine
- Pharmacological stimulation of Wnt/beta-catenin signaling pathway attenuates the course of thioacetamide-induced acute liver failure2020 | Third Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- Do diabetologists choose a therapy rationally? Basic results of the PROROK project (A prospective observation project to assess the relevance of the difference between fasting glycemia and postprandial glycemia to estimation of success of type 2 diabetes therapy)2015 | Second Faculty of Medicine